VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,873,676 | -3.2% | 2,708,052 | +8.3% | 24.11% | +21.3% |
Q2 2023 | $75,294,236 | -2.4% | 2,500,639 | +4.8% | 19.88% | -23.7% |
Q1 2023 | $77,184,378 | +20.8% | 2,385,916 | +7.0% | 26.05% | -1.4% |
Q4 2022 | $63,878,311 | -6.5% | 2,228,832 | -21.3% | 26.42% | -23.8% |
Q3 2022 | $68,310,000 | -6.3% | 2,832,115 | +6.3% | 34.65% | -3.6% |
Q2 2022 | $72,913,000 | -26.6% | 2,663,041 | +2.8% | 35.94% | +2.2% |
Q1 2022 | $99,338,000 | -16.3% | 2,590,335 | -30.1% | 35.16% | -13.8% |
Q4 2021 | $118,664,000 | +69.3% | 3,704,791 | +55.8% | 40.77% | +41.5% |
Q3 2021 | $70,075,000 | -9.1% | 2,377,855 | +4.8% | 28.82% | +10.9% |
Q2 2021 | $77,080,000 | +9.3% | 2,268,412 | +4.6% | 25.99% | -3.8% |
Q1 2021 | $70,498,000 | -9.3% | 2,169,200 | +0.5% | 27.01% | -3.5% |
Q4 2020 | $77,759,000 | +122.6% | 2,158,789 | +63.3% | 27.99% | -26.7% |
Q3 2016 | $34,934,000 | +24.6% | 1,321,823 | +30.7% | 38.20% | +18.4% |
Q2 2016 | $28,030,000 | – | 1,011,600 | – | 32.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |